HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Sandeep Tyagi Selected Research

moxifloxacin (Avelox)

8/2009Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
12/2007In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.
7/2006Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
12/2005Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
12/2005Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.
2/2004Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
6/2002Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Sandeep Tyagi Research Topics

Disease

9Tuberculosis (Tuberculoses)
09/2012 - 06/2002
3Infection
01/2011 - 12/2005
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
08/2009 - 06/2005
1Hypertension (High Blood Pressure)
07/2012
1Inflammation
10/2011
1Lung Neoplasms (Lung Cancer)
10/2011
1Obesity
10/2011
1Pain (Aches)
10/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2011
1Dyslipidemias (Dyslipidemia)
10/2011
1Shock
12/2005
1Latent Tuberculosis
12/2005
1Hypersensitivity (Allergy)
03/2004
1Body Weight (Weight, Body)
06/2002

Drug/Important Bio-Agent (IBA)

7moxifloxacin (Avelox)FDA Link
08/2009 - 06/2002
5Isoniazid (Ftivazide)FDA LinkGeneric
09/2012 - 06/2002
3PyrazinamideFDA LinkGeneric
09/2012 - 02/2004
3Rifampin (Rifampicin)FDA LinkGeneric
09/2012 - 02/2004
3rifapentine (Priftin)FDA Link
07/2006 - 12/2005
2Ethambutol (Myambutol)FDA LinkGeneric
09/2012 - 12/2005
2PA 824IBA
01/2011 - 06/2005
1Desoxycorticosterone (DOCA)FDA Link
07/2012
1atorvastatin (Lipitor)FDA Link
07/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
07/2012
1Acetylcholine (Acetylcholine Chloride)FDA Link
07/2012
12,4-thiazolidinedione (thiazolidinedione)IBA
07/2012
1Glutathione (Reduced Glutathione)IBA
07/2012
1Losartan (Cozaar)FDA LinkGeneric
07/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2011
1NitroimidazolesIBA
01/2011
1PNU-100480IBA
08/2009
1linezolid (Zyvox)FDA Link
08/2009
1rifamycin SVIBA
07/2006
1DNA (Deoxyribonucleic Acid)IBA
12/2005
1Ethionamide (Trecator-SC)FDA Link
12/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2004
1Tuberculin (PPD)IBA
03/2004

Therapy/Procedure

1Subcutaneous Injections
07/2012
1Drug Therapy (Chemotherapy)
02/2004